These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 27519791

  • 1. PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
    Han JY, Choi JJ, Kim JY, Han YL, Lee GK.
    BMC Cancer; 2016 Aug 12; 16():627. PubMed ID: 27519791
    [Abstract] [Full Text] [Related]

  • 2. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG, Paweletz C, Dahlberg SE, Alden RS, O'Connell A, Feeney N, Mach SL, Jänne PA, Oxnard GR.
    JAMA Oncol; 2016 Aug 01; 2(8):1014-22. PubMed ID: 27055085
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
    Karachaliou N, Mayo-de las Casas C, Queralt C, de Aguirre I, Melloni B, Cardenal F, Garcia-Gomez R, Massuti B, Sánchez JM, Porta R, Ponce-Aix S, Moran T, Carcereny E, Felip E, Bover I, Insa A, Reguart N, Isla D, Vergnenegre A, de Marinis F, Gervais R, Corre R, Paz-Ares L, Morales-Espinosa D, Viteri S, Drozdowskyj A, Jordana-Ariza N, Ramirez-Serrano JL, Molina-Vila MA, Rosell R, Spanish Lung Cancer Group.
    JAMA Oncol; 2015 May 01; 1(2):149-57. PubMed ID: 26181014
    [Abstract] [Full Text] [Related]

  • 9. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.
    Yoon SH, Choi YD, Oh IJ, Kim KS, Choi H, Chang J, Shin HJ, Park CK, Kim YC.
    Cancer Res Treat; 2015 Oct 01; 47(4):661-9. PubMed ID: 25715768
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.
    Wang S, An T, Wang J, Zhao J, Wang Z, Zhuo M, Bai H, Yang L, Zhang Y, Wang X, Duan J, Wang Y, Guo Q, Wu M.
    Clin Cancer Res; 2010 Feb 15; 16(4):1324-30. PubMed ID: 20145159
    [Abstract] [Full Text] [Related]

  • 12. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
    Ludovini V, Bianconi F, Pistola L, Chiari R, Minotti V, Colella R, Giuffrida D, Tofanetti FR, Siggillino A, Flacco A, Baldelli E, Iacono D, Mameli MG, Cavaliere A, Crinò L.
    J Thorac Oncol; 2011 Apr 15; 6(4):707-15. PubMed ID: 21258250
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
    Lambros L, Caumont C, Guibourg B, Barel F, Quintin-Roué I, Marcorelles P, Merlio JP, Uguen A.
    J Clin Pathol; 2017 Jun 15; 70(6):544-549. PubMed ID: 28153953
    [Abstract] [Full Text] [Related]

  • 14. Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao.
    Chan KI, Vong HT, Sin LF, Yip YC, Zhong XY, Wen JM.
    Clin Respir J; 2018 Apr 15; 12(4):1416-1423. PubMed ID: 28756651
    [Abstract] [Full Text] [Related]

  • 15. Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status.
    Duan H, Lu J, Lu T, Gao J, Zhang J, Xu Y, Wang M, Wu H, Liang Z, Liu T.
    Int J Clin Exp Pathol; 2015 Apr 15; 8(10):13136-45. PubMed ID: 26722512
    [Abstract] [Full Text] [Related]

  • 16. Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion.
    Kang JY, Park CK, Yeo CD, Lee HY, Rhee CK, Kim SJ, Kim SC, Kim YK, Park MS, Yim HW.
    Respirology; 2015 Jan 15; 20(1):138-46. PubMed ID: 25302858
    [Abstract] [Full Text] [Related]

  • 17. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.
    Lee SM, Bae SK, Jung SJ, Kim CK.
    Clin Nucl Med; 2015 Dec 15; 40(12):950-8. PubMed ID: 26359571
    [Abstract] [Full Text] [Related]

  • 18. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
    Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Prétet JL, Bièche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J.
    J Thorac Oncol; 2011 Jun 15; 6(6):1006-15. PubMed ID: 21532509
    [Abstract] [Full Text] [Related]

  • 19. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY.
    Lung Cancer; 2012 Mar 15; 75(3):321-5. PubMed ID: 21930325
    [Abstract] [Full Text] [Related]

  • 20. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD, Labiano T, Echeveste J, Gurpide A, Martín-Algarra S, Zhang G, Sharma A, Palma JF.
    Cancer Cytopathol; 2015 Apr 15; 123(4):230-6. PubMed ID: 25529460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.